台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效

生華科

(6492)
可現股當沖
  • 股價
    41.70
  • 漲跌
    ▲0.10
  • 漲幅
    +0.24%
  • 成交量
    63
  • 產業
    上櫃 生技醫療類股
  • 147人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
生華科 (6492)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/03/28     後一日»

券商獲利排行 - 2024/03/28

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  4.71%32.9032.9-1601643.6043.641.5
  4.71%16.4016.4-80843.6043.641.5
  4.49%11.7011.7-60643.5043.541.5
  4.93%10.8010.8-50543.7043.741.5
  4.82%10.5010.5-40543.643.643.641.5
  4.71%10.3010.3-50543.6043.641.5
  4.60%10010-50543.5043.541.5
  4.38%7.607.6-40443.443.743.441.5
  4.34%7.507.5-40443.443.843.441.5
  4.67%6.106.1-20343.543.643.541.5
  4.41%5.705.7-30343.4043.441.5
  4.93%4.304.3-10243.643.643.741.5
  4.93%4.304.3-20243.7043.741.5
  4.60%404-20243.5043.541.5
  4.88%2.102.100143.643.643.641.5
  4.82%2.102.1-10143.6043.641.5
  4.82%2.102.100143.64543.641.5
  4.82%2.102.1-10143.6043.641.5
  4.82%2.102.1-10143.6043.641.5
  4.60%202-10143.5043.541.5
  4.38%1.901.9-10143.4043.441.5
  4.16%1.801.8-10143.3043.341.5
  0.11%0.10.1001143.643.643.641.5
   00000043.743.7041.5
   00000043.943.9041.5
   00000044.144.1041.5
   00000043.643.6041.5
   00000043.543.5041.5
   0000004444041.5
   00000043.543.5041.5
   00000044.244.2041.5
   00000044.144.1041.5
   00000043.743.7041.5
   00000044.843.74541.5
   00000043.743.7041.5
   00000043.843.8041.5
   0000004444041.5
   00000043.843.8041.5
   00000044.344.3041.5
   00000043.943.9041.5
   00000043.543.5041.5
   00000043.543.5041.5
   00000044.444.4041.5
   00000043.943.9041.5
   00000043.543.5041.5
   00000044.244.2041.5
   00000043.643.6041.5
   00000043.743.7041.5
   0000004444041.5
   00000043.543.5041.5

券商虧損排行 - 2024/03/28

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -4.68%-48.90-48.92424043.543.5041.5
  -4.36%-20.80-20.81111043.443.4041.5
  -4.33%-15.1-0.2-14.978143.643.643.441.5
  -4.74%-12.40-12.466043.643.6041.5
  -4.60%-120-1266043.543.5041.5
  -4.51%-9.80-9.855043.543.5041.5
  -4.87%-4.30-4.322043.643.6041.5
  -4.82%-4.20-4.222043.643.6041.5
  -4.38%-3.80-3.822043.443.4041.5
  -4.93%-2.20-2.211043.743.7041.5
  -4.93%-2.20-2.211043.743.7041.5
  -4.83%-2.10-2.111043.643.6041.5
  -4.82%-2.10-2.111043.643.6041.5
  -4.82%-2.10-2.111043.643.6041.5
  -4.82%-2.10-2.111043.643.6041.5
  -4.82%-2.10-2.111043.643.6041.5
  -4.71%-2.10-2.111043.643.6041.5
  -4.60%-20-211043.543.5041.5
  -4.49%-20-201043.543.543.841.5
  -4.38%-1.90-1.911043.443.4041.5
  -4.38%-1.90-1.911043.443.4041.5
  -4.16%-1.80-1.811043.343.3041.5
  -0.25%-0.3-0.3003343.543.643.541.5
  -0.57%-0.3-0.3001143.543.743.441.5
   00000044.444.4041.5
   00000043.843.8041.5
   00000043.843.8041.5
   00000043.8043.841.5
   00000043.543.5041.5
   00000043.743.7041.5
   00000043.543.5041.5
   0000004444041.5
   00000044.344.3041.5
   00000043.543.5041.5
   0000004444041.5
   00000043.843.8041.5
   00000044.544.5041.5
   00000043.743.7041.5
   00000043.543.5041.5
   00000044.244.2041.5
   00000043.743.7041.5
   00000043.943.9041.5
   00000044.144.1041.5
   00000043.643.6041.5
   00000043.543.5041.5
   0000004444041.5
   00000043.543.5041.5
   00000044.244.2041.5
   00000044.144.1041.5
   00000043.743.7041.5
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-30天前
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科泛病毒感染肺炎新藥 向美申請二期臨床Anue鉅亨-2023/10/19
生華科 相關文章
生華科 相關影音